CSIMarket
 


Jaguar Health inc   (JAGX)
Other Ticker:  
 
 

JAGX's Revenue Growth by Quarter and Year

Jaguar Health Inc 's Revenue results by quarter and year




JAGX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 3.26 2.08 2.58
III Quarter September 2.81 3.15 0.63 2.77
II Quarter June 2.68 2.92 0.39 3.17
I Quarter March 1.97 2.63 1.24 0.87
FY   7.46 11.96 4.34 9.39



JAGX Revenue third quarter 2023 Y/Y Growth Comment
Jaguar Health Inc reported fall in Revenue in the third quarter 2023 by -10.7% to $ 2.81 millions, from the same quarter in 2022.
The decline in the third quarter 2023 Jaguar Health Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 260.72%.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 71 other companies have achieved higher Revenue growth. While Jaguar Health Inc ' s Revenue decrease of -10.7% ranks overall at the positon no. 484 in the third quarter 2023.




JAGX Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 56.73 % -19.38 % 70.86 %
III Quarter September -10.7 % 400 % -77.26 % 185.57 %
II Quarter June -8.22 % 648.72 % -87.7 % 85.38 %
I Quarter March -25.1 % 112.1 % 42.53 % -45.28 %
FY   - 175.58 % -53.78 % 62.46 %

Financial Statements
Jaguar Health Inc 's third quarter 2023 Revenue $ 2.81 millions JAGX's Income Statement
Jaguar Health Inc 's third quarter 2022 Revenue $ 3.15 millions Quarterly JAGX's Income Statement
New: More JAGX's historic Revenue Growth >>


JAGX Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 3.49 % 230.16 % -6.86 %
III Quarter September 4.96 % 7.88 % 61.54 % -12.62 %
II Quarter June 36.04 % 11.03 % -68.55 % 264.37 %
I Quarter March -39.57 % 26.44 % -51.94 % -42.38 %
FY (Year on Year)   - 175.58 % -53.78 % 62.46 %




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #72
Healthcare Sector #144
Overall #484

Revenue Y/Y Growth Statistics
High Average Low
2981.61 % 260.72 % -53.81 %
(Dec 31 2017)   (Dec 31 2021)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #72
Healthcare Sector #144
Overall #484
Revenue Y/Y Growth Statistics
High Average Low
2981.61 % 260.72 % -53.81 %
(Dec 31 2017)   (Dec 31 2021)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Jaguar Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2747.98 % 107.99 % -68.98 %
(Mar 31 2017)  


JAGX's III. Quarter Q/Q Revenue Comment
Jaguar Health inc achieved in the III. Quarter 2023 below company average Revenue growth of 4.96% quarter on quarter, to $ 2.81 millions.

Within Major Pharmaceutical Preparations industry 100 other companies have achieved higher Revenue quarter on quarter growth. While Jaguar Health Inc 's Revenue growth quarter on quarter, overall rank is 982.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #101
Healthcare Sector #206
Overall #982
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #101
Healthcare Sector #206
Overall #982
Revenue Q/Q Growth Statistics
High Average Low
2747.98 % 107.99 % -68.98 %
(Mar 31 2017)  


JAGX's III. Quarter Q/Q Revenue Comment
Jaguar Health inc achieved in the III. Quarter 2023 below company average Revenue growth of 4.96% quarter on quarter, to $ 2.81 millions.

Within Major Pharmaceutical Preparations industry 100 other companies have achieved higher Revenue quarter on quarter growth. While Jaguar Health Inc 's Revenue growth quarter on quarter, overall rank is 982.


Jaguar Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 10.72 $ 11.06 $ 11.30 $ 11.96 $ 10.78
Y / Y Revenue Growth (TTM) -0.5 % 33.96 % 97.64 % 175.8 % 122.99 %
Year on Year Revenue Growth Overall Ranking # 164 # 954 # 3010 # 2921 # 3476
Seqeuential Revenue Change (TTM) -3.05 % -2.17 % -5.46 % 10.96 % 30.53 %
Seq. Revenue Growth (TTM) Overall Ranking # 577 # 528 # 737 # 2611 # 3169




Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2023 Jaguar Health Inc reported a decrease in Revenue by -0.5% year on year, to $11 millions, compare to the 33.96% growth at Jun 30 2023.

In the Healthcare sector 57 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 164, from total ranking in previous quarter at 954.

Revenue TTM Q/Q Growth Statistics
High Average Low
2981.61 %
260.72 %
-53.81 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 76
Healthcare Sector # 58
Overall # 164

Revenue TTM Y/Y Growth Statistics
High Average Low
2981.61 %
260.72 %
-53.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 76
Sector # 161
S&P 500 # 577
Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2023 Jaguar Health Inc reported a decrease in Revenue by -0.5% year on year, to $11 millions, compare to the 33.96% growth at Jun 30 2023.

In the Healthcare sector 57 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 164, from total ranking in previous quarter at 954.

Revenue TTM Q/Q Growth Statistics
High Average Low
2981.61 %
260.72 %
-53.81 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 76
Healthcare Sector # 58
Overall # 164

Revenue TTM Y/Y Growth Statistics
High Average Low
2981.61 %
260.72 %
-53.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 76
Sector # 161
S&P 500 # 577




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
JAGX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for JAGX's Competitors
Revenue Growth for Jaguar Health Inc 's Suppliers
Revenue Growth for JAGX's Customers

You may also want to know
JAGX's Annual Growth Rates JAGX's Profitability Ratios JAGX's Asset Turnover Ratio JAGX's Dividend Growth
JAGX's Roe JAGX's Valuation Ratios JAGX's Financial Strength Ratios JAGX's Dividend Payout Ratio
JAGX's Roa JAGX's Inventory Turnover Ratio JAGX's Growth Rates JAGX's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Procyon Corporation-0.22%$ -0.221 millions
Amedisys Inc -0.31%$ -0.314 millions
Karyopharm Therapeutics Inc -0.38%$ -0.376 millions
Establishment Labs Holdings Inc -0.50%$ -0.505 millions
Opko Health Inc -0.64%$ -0.639 millions
Integra Lifesciences Holdings Corp-0.72%$ -0.719 millions
Healthcare Services Group Inc -0.75%$ -0.748 millions
Phibro Animal Health Corporation-0.77%$ -0.772 millions
Bellicum Pharmaceuticals Inc -0.89%$ -0.890 millions
Prestige Consumer Healthcare Inc -1.12%$ -1.125 millions
Sharecare Inc -1.13%$ -1.127 millions
Lifevantage Corp-1.14%$ -1.140 millions
Organon and Co -1.17%$ -1.171 millions
Optinose Inc -1.27%$ -1.270 millions
Baxter International Inc -1.72%$ -1.723 millions
Puma Biotechnology Inc -1.73%$ -1.727 millions
Blueprint Medicines Corporation-1.76%$ -1.763 millions
Standard Biotools Inc -1.92%$ -1.918 millions
Pacira Biosciences inc -2.11%$ -2.114 millions
Bristol myers Squibb Company-2.25%$ -2.246 millions
Aurinia Pharmaceuticals Inc -2.27%$ -2.266 millions
Abbott Laboratories-2.56%$ -2.565 millions
Enhabit Inc -2.79%$ -2.785 millions
Novocure Limited-2.81%$ -2.807 millions
Uniqure N v -2.90%$ -2.899 millions
Vaso Corporation-2.92%$ -2.925 millions
Scientific Industries Inc -3.16%$ -3.165 millions
Akumin Inc -3.21%$ -3.205 millions
Syros Pharmaceuticals Inc -3.32%$ -3.315 millions
Viatris Inc -3.34%$ -3.342 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com